Profusa, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
PFSA$0.55-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Deficit
FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023
| Common stock · Additional Paid-In · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Deficit | |
| Balance as of December 31, 2022 | 5,193,750 | $519 | $— | $(619,995) | $(619,476) |
| Accretion of common stock to redemption value | — | — | — | (2,137,638) | (2,137,638) |
| Excise tax payable attributable to redemption of common stock | — | — | — | (1,864,106) | (1,864,106) |
| Net income | — | — | — | 1,161,910 | 1,161,910 |
| Balance as of December 31, 2023 | 5,193,750 | $519 | $— | $(3,459,829) | $(3,459,310) |
| Common stock · Additional Paid-In · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Deficit | |
| Balance as of December 31, 2023 | 5,193,750 | $519 | $— | $(3,459,829) | $(3,459,310) |
| Accretion of common stock to redemption value | — | — | — | (768,980) | (768,980) |
| Excise tax payable attributable to redemption of common stock | — | — | — | (16,838) | (16,838) |
| Net loss | — | — | — | (8,711,619) | (8,711,619) |
| Balance as of December 31, 2024 | 5,193,750 | $519 | $— | $(12,957,266) | $(12,956,747) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.